Pharmaceuticals

Global Onchocerciasis Treatment Industry Insights: Key Trends and Growth Estimates

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the onchocerciasis treatment market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Onchocerciasis Treatment Market?

The onchocerciasis treatment market has observed considerable expansion over recent years. Its value is projected to rise from $1.11 billion in 2025 to $1.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. The growth seen historically can be attributed to several factors, including the limited availability of ivermectin and doxycycline in endemic regions, a reliance on hospital-based distribution channels, low awareness concerning onchocerciasis management, inadequate preventive chemotherapy programs, and a dependency solely on oral formulations.

The onchocerciasis treatment market is projected to experience substantial expansion in the coming years. This market is predicted to reach $1.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. Several factors are expected to drive this growth during the forecast period, including the introduction of moxidectin and new long-acting formulations, the broadening reach of online and retail pharmacy distribution channels, the advancement of combination therapies, increased financial support from government bodies and NGOs for eradication initiatives, and the implementation of community-focused preventive strategies. Key trends anticipated during this period encompass the expansion of mass drug administration (mda) programs, the creation of pediatric and fixed-dose drug formulations, a heightened emphasis on anti-wolbachia therapies, the integration of both oral and injectable treatment protocols, and the rise of treatment campaigns supported by communities and governments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

Which Drivers Are Supporting The Rise Of The Onchocerciasis Treatment Market?

An increase in individuals experiencing eye-related problems is anticipated to drive the expansion of the onchocerciasis treatment market. These problems encompass various conditions impacting sight and eye health, such as infections, injuries, and long-term ailments like glaucoma or cataracts. The main reason for this surge in patients is greater screen time and extended contact with digital screens. Treatments for onchocerciasis aid in preventing and addressing vision impairment and blindness by eradicating the parasitic infection responsible for inflammation and harm to eye tissues. For example, in May 2024, data from the Centers for Disease Control and Prevention (CDC), a US public health organization, indicated that approximately 20.5 million Americans aged over 40 had cataracts in at least one eye, representing 17.2% of that demographic. Projections suggest that close to 30 million people will develop cataracts by 2028. Consequently, the growing occurrence of eye conditions is fueling the expansion of the onchocerciasis treatment market. Anticipated expansion of the onchocerciasis treatment market is linked to an increasing need for surgical interventions. These procedures involve medical operations designed to excise or mend tissues harmed by illness, frequently employed when pharmaceutical remedies fail or when long-term health is jeopardized by complications. The uptick is primarily due to onchocerciasis advancing to severe stages in certain individuals, necessitating surgery to avert irreversible harm like vision impairment or physical disfigurement. Consequently, medical service providers are enhancing surgical offerings and allocating resources to sophisticated methods, which in turn stimulates the broader market for onchocerciasis treatment. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US professional organization for certified aesthetic plastic surgeons, reported that almost 35 million aesthetic procedures were carried out globally in 2023, showing a 3.4% rise from 2022. The same report also noted a 5.5% increase in surgical procedures, with over 15.8 million performed by plastic surgeons. Thus, the heightened requirement for surgical interventions is propelling expansion in the onchocerciasis treatment market.

What Leading Segments Are Studied In The Onchocerciasis Treatment Market?

The onchocerciasis treatment market covered in this report is segmented –

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

Which Trends Are Guiding The Evolution Of The Onchocerciasis Treatment Market?

Companies prominent in the onchocerciasis treatment market are prioritizing the development of innovative antiparasitic drugs to enhance the effectiveness and decrease the duration of treatment. Antiparasitic medications are agents specifically designed to eliminate or suppress parasites like worms and protozoa that cause human infections. For example, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical organization, obtained approval from the Ghana Food and Drugs Authority (FDA) for its Moxidectin 2 mg oral tablets for treating river blindness in individuals aged 4 years and older. This approval empowers Ghana to implement community-based mass drug administration programs using moxidectin, which provides greater efficacy and more lasting effects compared to ivermectin. With this authorization, MDGH aims to expand access to an effective new onchocerciasis treatment, enabling large-scale community initiatives in regions where the disease is endemic.

Which Major Industry Participants Are Leading The Onchocerciasis Treatment Market Growth?

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/onchocerciasis-treatment-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Onchocerciasis Treatment Market?

North America was the largest region in the onchocerciasis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Onchocerciasis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24634&type=smp

Browse Through More Reports Similar to the Global Onchocerciasis Treatment Market 2026, By The Business Research Company

Oncology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Oncology Companion Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

Oncologists Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795